e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Drug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Extensively drug-resistant tuberculosis in the penitentiary facilities of the Russian Federation
L. Rusakova (Moscow, Russian Federation), S. Sterlikov (Moscow, Russian Federation), S. Ponomarev (Moscow, Russian Federation)
Source:
International Congress 2018 – Drug-resistant tuberculosis
Session:
Drug-resistant tuberculosis
Session type:
Poster Discussion
Number:
3683
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Rusakova (Moscow, Russian Federation), S. Sterlikov (Moscow, Russian Federation), S. Ponomarev (Moscow, Russian Federation). Extensively drug-resistant tuberculosis in the penitentiary facilities of the Russian Federation. 3683
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Drug resistance of Mycobacterium tuberculosis in the Ural region of Russian Federation
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Estimation of XDR-TB in European part of the Russian Federation
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
XDR-TB prevalence in some regions of the Russian Federation
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017
Treatment outcomes of the use of moxifloxacin in management of patients with XDR-TB in Tomsk Oblast of the Russian Federation
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008
Population-based study of fluoroquinolone-resistance in clinical isolates of Mycobacterium tuberculosis in Novosibirsk Oblast, Russian Federation
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Treatment of multidrug resistant tuberculosis in penitentiary system of Tomsk Oblast
Source: Eur Respir J 2001; 18: Suppl. 33, 338s
Year: 2001
Demographic characteristics of drug-resistant tuberculosis in the Russian Federation
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
ERS/WHO Tuberculosis Consilium assistance in extensively drug-resistant tuberculosis
Source: Eur Respir J 2015; 45: 294-295
Year: 2015
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Epidemiologic situation on TB in penitentiary constitutions of Russian Federation
Source: Annual Congress 2010 - Tuberculosis epidemiology
Year: 2010
Fighting tuberculosis in the EU/EEA: towards the new European Union standards on tuberculosis care
Source: Eur Respir J 2016; 48: 1278-1281
Year: 2016
Multidrug-resistant strains of M. tuberculosis circulated in penitentiary system in Kyrgyz Republic
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
The risk of default in TB patients in the Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
The distribution of Beijing genotype among mycobacterium tuberculosis strains obtained from patients of different dispensary registration groups from Nizhny Novgorod region of the Russian Federation in 2013-2014
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Tuberculosis treatment outcomes in HIV co-infected patients in Novokuznetsk, Russian Federation
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
Tuberculosis prophylaxis in HIV patients in Tomsk penitentiary system, Russia
Source: Annual Congress 2008 - COPD and miscellaneous
Year: 2008
Drug-resistant tuberculosis in the European Union and European economic area
Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Year: 2015
New approaches to treatment of HIV-associated tuberculosis in penitentiary institutions of Belarus
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept